Planned oocyte cryopreservation: the state of the ART
•Oocyte cryopreservation increases reproductive autonomy and promotes social justice.•This technology does not seem to pose more safety risks than IVF.•The use of oocyte cryopreservation is increasing, but many questions still remain.•The age at cryopreservation and number of cryopreserved oocytes i...
Gespeichert in:
| Veröffentlicht in: | Reproductive biomedicine online 2023-12, Vol.47 (6), p.103367-103367, Article 103367 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 103367 |
|---|---|
| container_issue | 6 |
| container_start_page | 103367 |
| container_title | Reproductive biomedicine online |
| container_volume | 47 |
| creator | Cascante, Sarah Druckenmiller Berkeley, Alan S. Licciardi, Frederick McCaffrey, Caroline Grifo, James A. |
| description | •Oocyte cryopreservation increases reproductive autonomy and promotes social justice.•This technology does not seem to pose more safety risks than IVF.•The use of oocyte cryopreservation is increasing, but many questions still remain.•The age at cryopreservation and number of cryopreserved oocytes impact the success.•Cryopreservation of ≥20 mature oocytes at |
| doi_str_mv | 10.1016/j.rbmo.2023.103367 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2874258334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1472648323004662</els_id><sourcerecordid>2874258334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-c9d907cd4e41e18f22dbf2b4ab5e25c49c00b7eeabc191383a7213dc01ca33e23</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbK3-AQ-So5fU2Y8kG_FSil9QUKSel83uBFOabN1NC_n3pqb26Gm-3nmZeQi5pjClQNO71dQXtZsyYLxvcJ5mJ2RMRcbiVOT09JhLPiIXIawAqATJz8mIZxJECumYJO9r3TRoI-dM12JkfOc2HgP6nW4r19xH7RdGodX9zJW_xexjeUnOSr0OeHWIE_L59Licv8SLt-fX-WwRGwHQxia3OWTGChQUqSwZs0XJCqGLBFliRG4AigxRF4bmlEuuM0a5NUCN5hwZn5DbwXfj3fcWQ6vqKhhc9zej2wbFZCZYIjkXvZQNUuNdCB5LtfFVrX2nKKg9LrVSe1xqj0sNuPqlm4P_tqjRHlf--PSCh0GA_Ze7Cr0KpsLGoK08mlZZV_3n_wP5QHqx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2874258334</pqid></control><display><type>article</type><title>Planned oocyte cryopreservation: the state of the ART</title><source>MEDLINE</source><source>ScienceDirect</source><creator>Cascante, Sarah Druckenmiller ; Berkeley, Alan S. ; Licciardi, Frederick ; McCaffrey, Caroline ; Grifo, James A.</creator><creatorcontrib>Cascante, Sarah Druckenmiller ; Berkeley, Alan S. ; Licciardi, Frederick ; McCaffrey, Caroline ; Grifo, James A.</creatorcontrib><description>•Oocyte cryopreservation increases reproductive autonomy and promotes social justice.•This technology does not seem to pose more safety risks than IVF.•The use of oocyte cryopreservation is increasing, but many questions still remain.•The age at cryopreservation and number of cryopreserved oocytes impact the success.•Cryopreservation of ≥20 mature oocytes at <38 years of age seems to bestow a 70% live birth rate.
The objective of this review is to provide an update on planned oocyte cryopreservation. This fertility preservation method increases reproductive autonomy by allowing women to postpone childbearing whilst maintaining the option of having a biological child. Oocyte cryopreservation is no longer considered experimental, and its use has increased dramatically in recent years as more women delay childbearing for personal, professional and financial reasons. Despite increased usage, most patients who have undergone oocyte cryopreservation have not yet warmed their oocytes. Most women who cryopreserve oocytes wait years to use them, and many never use them. Studies have demonstrated that oocyte cryopreservation results in live birth rates comparable with IVF treatment using fresh oocytes, and does not pose additional safety risks to offspring. Based on current evidence, cryopreserving ≥20 mature oocytes at <38 years of age provides a 70% chance of one live birth. However, larger studies from a variety of geographic locations and centre types are needed to confirm these findings. Additional research is also needed to determine the recommended age for oocyte cryopreservation, recommended number of oocytes to cryopreserve, return and discard/non-use rates, cost-effectiveness, and how best to distribute accurate and up-to-date information to potential patients.</description><identifier>ISSN: 1472-6483</identifier><identifier>EISSN: 1472-6491</identifier><identifier>DOI: 10.1016/j.rbmo.2023.103367</identifier><identifier>PMID: 37804606</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Birth Rate ; Child ; Cryopreservation - methods ; Delayed childbearing ; Egg freezing ; Female ; Fertility preservation ; Fertility Preservation - methods ; Humans ; Live Birth ; Oocyte cryopreservation ; Oocyte thaw ; Oocyte warming ; Oocytes ; Pregnancy</subject><ispartof>Reproductive biomedicine online, 2023-12, Vol.47 (6), p.103367-103367, Article 103367</ispartof><rights>2023 The Authors</rights><rights>Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-c9d907cd4e41e18f22dbf2b4ab5e25c49c00b7eeabc191383a7213dc01ca33e23</citedby><cites>FETCH-LOGICAL-c400t-c9d907cd4e41e18f22dbf2b4ab5e25c49c00b7eeabc191383a7213dc01ca33e23</cites><orcidid>0000-0003-4479-0713</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.rbmo.2023.103367$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37804606$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cascante, Sarah Druckenmiller</creatorcontrib><creatorcontrib>Berkeley, Alan S.</creatorcontrib><creatorcontrib>Licciardi, Frederick</creatorcontrib><creatorcontrib>McCaffrey, Caroline</creatorcontrib><creatorcontrib>Grifo, James A.</creatorcontrib><title>Planned oocyte cryopreservation: the state of the ART</title><title>Reproductive biomedicine online</title><addtitle>Reprod Biomed Online</addtitle><description>•Oocyte cryopreservation increases reproductive autonomy and promotes social justice.•This technology does not seem to pose more safety risks than IVF.•The use of oocyte cryopreservation is increasing, but many questions still remain.•The age at cryopreservation and number of cryopreserved oocytes impact the success.•Cryopreservation of ≥20 mature oocytes at <38 years of age seems to bestow a 70% live birth rate.
The objective of this review is to provide an update on planned oocyte cryopreservation. This fertility preservation method increases reproductive autonomy by allowing women to postpone childbearing whilst maintaining the option of having a biological child. Oocyte cryopreservation is no longer considered experimental, and its use has increased dramatically in recent years as more women delay childbearing for personal, professional and financial reasons. Despite increased usage, most patients who have undergone oocyte cryopreservation have not yet warmed their oocytes. Most women who cryopreserve oocytes wait years to use them, and many never use them. Studies have demonstrated that oocyte cryopreservation results in live birth rates comparable with IVF treatment using fresh oocytes, and does not pose additional safety risks to offspring. Based on current evidence, cryopreserving ≥20 mature oocytes at <38 years of age provides a 70% chance of one live birth. However, larger studies from a variety of geographic locations and centre types are needed to confirm these findings. Additional research is also needed to determine the recommended age for oocyte cryopreservation, recommended number of oocytes to cryopreserve, return and discard/non-use rates, cost-effectiveness, and how best to distribute accurate and up-to-date information to potential patients.</description><subject>Birth Rate</subject><subject>Child</subject><subject>Cryopreservation - methods</subject><subject>Delayed childbearing</subject><subject>Egg freezing</subject><subject>Female</subject><subject>Fertility preservation</subject><subject>Fertility Preservation - methods</subject><subject>Humans</subject><subject>Live Birth</subject><subject>Oocyte cryopreservation</subject><subject>Oocyte thaw</subject><subject>Oocyte warming</subject><subject>Oocytes</subject><subject>Pregnancy</subject><issn>1472-6483</issn><issn>1472-6491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1Lw0AQhhdRbK3-AQ-So5fU2Y8kG_FSil9QUKSel83uBFOabN1NC_n3pqb26Gm-3nmZeQi5pjClQNO71dQXtZsyYLxvcJ5mJ2RMRcbiVOT09JhLPiIXIawAqATJz8mIZxJECumYJO9r3TRoI-dM12JkfOc2HgP6nW4r19xH7RdGodX9zJW_xexjeUnOSr0OeHWIE_L59Licv8SLt-fX-WwRGwHQxia3OWTGChQUqSwZs0XJCqGLBFliRG4AigxRF4bmlEuuM0a5NUCN5hwZn5DbwXfj3fcWQ6vqKhhc9zej2wbFZCZYIjkXvZQNUuNdCB5LtfFVrX2nKKg9LrVSe1xqj0sNuPqlm4P_tqjRHlf--PSCh0GA_Ze7Cr0KpsLGoK08mlZZV_3n_wP5QHqx</recordid><startdate>202312</startdate><enddate>202312</enddate><creator>Cascante, Sarah Druckenmiller</creator><creator>Berkeley, Alan S.</creator><creator>Licciardi, Frederick</creator><creator>McCaffrey, Caroline</creator><creator>Grifo, James A.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4479-0713</orcidid></search><sort><creationdate>202312</creationdate><title>Planned oocyte cryopreservation: the state of the ART</title><author>Cascante, Sarah Druckenmiller ; Berkeley, Alan S. ; Licciardi, Frederick ; McCaffrey, Caroline ; Grifo, James A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-c9d907cd4e41e18f22dbf2b4ab5e25c49c00b7eeabc191383a7213dc01ca33e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Birth Rate</topic><topic>Child</topic><topic>Cryopreservation - methods</topic><topic>Delayed childbearing</topic><topic>Egg freezing</topic><topic>Female</topic><topic>Fertility preservation</topic><topic>Fertility Preservation - methods</topic><topic>Humans</topic><topic>Live Birth</topic><topic>Oocyte cryopreservation</topic><topic>Oocyte thaw</topic><topic>Oocyte warming</topic><topic>Oocytes</topic><topic>Pregnancy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cascante, Sarah Druckenmiller</creatorcontrib><creatorcontrib>Berkeley, Alan S.</creatorcontrib><creatorcontrib>Licciardi, Frederick</creatorcontrib><creatorcontrib>McCaffrey, Caroline</creatorcontrib><creatorcontrib>Grifo, James A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Reproductive biomedicine online</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cascante, Sarah Druckenmiller</au><au>Berkeley, Alan S.</au><au>Licciardi, Frederick</au><au>McCaffrey, Caroline</au><au>Grifo, James A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Planned oocyte cryopreservation: the state of the ART</atitle><jtitle>Reproductive biomedicine online</jtitle><addtitle>Reprod Biomed Online</addtitle><date>2023-12</date><risdate>2023</risdate><volume>47</volume><issue>6</issue><spage>103367</spage><epage>103367</epage><pages>103367-103367</pages><artnum>103367</artnum><issn>1472-6483</issn><eissn>1472-6491</eissn><abstract>•Oocyte cryopreservation increases reproductive autonomy and promotes social justice.•This technology does not seem to pose more safety risks than IVF.•The use of oocyte cryopreservation is increasing, but many questions still remain.•The age at cryopreservation and number of cryopreserved oocytes impact the success.•Cryopreservation of ≥20 mature oocytes at <38 years of age seems to bestow a 70% live birth rate.
The objective of this review is to provide an update on planned oocyte cryopreservation. This fertility preservation method increases reproductive autonomy by allowing women to postpone childbearing whilst maintaining the option of having a biological child. Oocyte cryopreservation is no longer considered experimental, and its use has increased dramatically in recent years as more women delay childbearing for personal, professional and financial reasons. Despite increased usage, most patients who have undergone oocyte cryopreservation have not yet warmed their oocytes. Most women who cryopreserve oocytes wait years to use them, and many never use them. Studies have demonstrated that oocyte cryopreservation results in live birth rates comparable with IVF treatment using fresh oocytes, and does not pose additional safety risks to offspring. Based on current evidence, cryopreserving ≥20 mature oocytes at <38 years of age provides a 70% chance of one live birth. However, larger studies from a variety of geographic locations and centre types are needed to confirm these findings. Additional research is also needed to determine the recommended age for oocyte cryopreservation, recommended number of oocytes to cryopreserve, return and discard/non-use rates, cost-effectiveness, and how best to distribute accurate and up-to-date information to potential patients.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>37804606</pmid><doi>10.1016/j.rbmo.2023.103367</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4479-0713</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1472-6483 |
| ispartof | Reproductive biomedicine online, 2023-12, Vol.47 (6), p.103367-103367, Article 103367 |
| issn | 1472-6483 1472-6491 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2874258334 |
| source | MEDLINE; ScienceDirect |
| subjects | Birth Rate Child Cryopreservation - methods Delayed childbearing Egg freezing Female Fertility preservation Fertility Preservation - methods Humans Live Birth Oocyte cryopreservation Oocyte thaw Oocyte warming Oocytes Pregnancy |
| title | Planned oocyte cryopreservation: the state of the ART |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T19%3A49%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Planned%20oocyte%20cryopreservation:%20the%20state%20of%20the%20ART&rft.jtitle=Reproductive%20biomedicine%20online&rft.au=Cascante,%20Sarah%20Druckenmiller&rft.date=2023-12&rft.volume=47&rft.issue=6&rft.spage=103367&rft.epage=103367&rft.pages=103367-103367&rft.artnum=103367&rft.issn=1472-6483&rft.eissn=1472-6491&rft_id=info:doi/10.1016/j.rbmo.2023.103367&rft_dat=%3Cproquest_cross%3E2874258334%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2874258334&rft_id=info:pmid/37804606&rft_els_id=S1472648323004662&rfr_iscdi=true |